Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
STIL centriolar assembly protein (STIL) is a cytoplasmic protein crucial for centriole replication and for de novo centriole biogenesis, which is essential during mammalian embryogenesis[1]. It regulates the mitotic spindle checkpoint to monitor chromosome segregation, ensuring proper distribution of chromosomes during cell division, and is required for activating the spindle checkpoint through its interaction with mitotic regulators. STIL has fundamental roles in cell cycle progression, cell proliferation, and embryonic development. Loss-of-function mutations in STIL are linked to autosomal recessive primary microcephaly (MCPH7), and chromosomal deletions involving STIL are seen in some forms of T-cell leukemia[2][3]. At a molecular level, STIL interacts with other centriolar proteins such as CPAP and PLK4, participating in the assembly and duplication of centrioles via its coiled-coil domain[1][3]. No approved drugs directly target STIL, but its genetic alterations function as disease biomarkers in some contexts[2][3].
Not applicable for drugs, as no direct pharmacological modulators are known.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on STIL centriolar assembly protein (STIL).